Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Healthcare Stocks to Buy Hand Over Fist in June


We're almost halfway through the year, and so far, it's been a pretty solid one for equity markets. It's as good a time as any to review one's portfolio and potentially consider putting more money into stocks with the understanding that our current bull market won't last forever. So, as always, it's essential to invest in stocks that can perform well over long periods, regardless of how they may be doing right now.

For those who need a bit of inspiration on that front, let's consider two stocks in the healthcare field that have what it takes to deliver excellent returns to patient investors: Vertex Pharmaceuticals (NASDAQ: VRTX) and Abbott Laboratories (NYSE: ABT).

Vertex Pharmaceuticals develops medicines, and like most companies in this business, success comes largely from innovation. That's precisely why Vertex has been an above-average performer for over a decade; the company continues to market newer and better therapies.

Continue reading


Source Fool.com

Vertex Pharmaceuticals Inc. Stock

€452.20
0.070%
There is nearly no change for the Vertex Pharmaceuticals Inc. stock today. Compared to yesterday it only changed by €0.30.
With 52 Buy predictions and 2 Sell predictions Vertex Pharmaceuticals Inc. is one of the favorites of our community.
However, we have a potential of -4.02% for Vertex Pharmaceuticals Inc. as the target price of 434 € is below the current price of 452.2 €.
Like: 0
Share

Comments